文献速递免疫规划传染病防控与疫情报告

疫苗对alpha、delta和omicron SARS-CoV-2感染传播的有效性,比利时接触者追踪,2021-2022年

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.
PubMed 文献 · Vaccine · 2023-04-05

基于比利时2021年1月至2022年1月接触者追踪数据,采用多水平贝叶斯回归模型估计疫苗对SARS-CoV-2传播的有效性(VET)。结果显示,针对Alpha、Delta和Omicron的初种VET分别为96%、87%和31%,加强针后针对Delta和Omicron的VET分别为87%和68%,且随时间下降;混合免疫与持久且更高或相当的传播保护相关。

要点

  • 初种BNT162b2对Alpha、Delta和Omicron的VET分别为96%、87%和31%。
  • 加强接种后对Delta和Omicron的VET分别为87%和68%,150-200天后降至71%和55%。
  • 混合免疫与持久且更高或相当的传播保护相关。

核心结论

  • 尽管观察到变异株特异性免疫逃逸(尤其是Omicron)和免疫后时间衰减,疫苗接种仍与SARS-CoV-2传播风险降低相关。

研究设计与样本

  • 研究采用多水平贝叶斯回归模型,拟合比利时2021年1月至2022年1月接触者追踪中高风险暴露接触者的RT-PCR检测结果与免疫状态、年龄、性别、采样日历周、家庭、背景阳性率和优势变异株。

主要发现

  • 初种BNT162b2疫苗对Alpha的初始VET为96%(95%CI 95-97),对Delta为87%(95%CI 84-88),对Omicron为31%(95%CI 25-37)。
  • 加强接种(mRNA初种加加强)对Delta的初始VET为87%(95%CI 86-89),对Omicron为68%(95%CI 65-70)。
  • 加强接种后150-200天,对Delta的VET降至71%(95%CI 64-78),对Omicron降至55%(95%CI 46-62)。
  • 混合免疫(疫苗接种且有记录既往感染)与持久且更高或相当(按抗原暴露次数)的传播保护相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Vaccine effectiveness against transmission (VET) of SARS-CoV-2-infection can be estimated from secondary attack rates observed during contact tracing. We estimated VET, the vaccine-effect on infectiousness of the index case and susceptibility of the high-risk exposure contact (HREC). METHODS: We fitted RT-PCR-test results from HREC to immunity status (vaccine schedule, prior infection, time since last immunity-conferring event), age, sex, calendar week of sampling, household, background positivity rate and dominant VOC using a multilevel Bayesian regression-model. We included Belgian data collected between January 2021 and January 2022. RESULTS: For primary BNT162b2-vaccination we estimated initial VET at 96% (95%CI 95-97) against Alpha, 87% (95%CI 84-88) against Delta and 31% (95%CI 25-37) against Omicron. Initial VET of booster-vaccination (mRNA primary and booster-vaccination) was 87% (95%CI 86-89) against Delta and 68% (95%CI 65-70) against Omicron. The VET-estimate against Delta and Omicron decreased to 71% (95%CI 64-78) and 55% (95%CI 46-62) respectively, 150-200 days after booster-vaccination. Hybrid immunity, defined as vaccination and documented prior infection, was associated with durable and higher or comparable (by number of antigen exposures) protection against transmission. CONCLUSIONS: While we observed VOC-specific immune-escape, especially by Omicron, and waning over time since immunization, vaccination remained associated with a reduced risk of SARS-CoV-2-transmission.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Braeye T, Catteau L, Brondeel R, et al. Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022. Vaccine. 2023. PMID: 37085456. doi:10.1016/j.vaccine.2023.03.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。